ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryAssociations & Interest GroupsNGOs & NPOsZürichNovo Nordisk Hämophilie & Hämoglobinopathien Stiftung
Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung develops and supplies medicines and injection systems for people living with serious chronic diseases. Its activities focus on treatments for diabetes, obesity and other chronic conditions, as well as research and clinical trials.

AI-generated
Offering

Products & services

Industry:
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.2/5

Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung

NGOs & NPOs
✓ Offered2
Research and Development for Therapies
Research into targeted treatment options and medical devices for severe chronic diseases; development of innovations for treating people living with these conditions.
Anti-counterfeiting Measures
Countering counterfeit medicines, with guidance on safe supply channels through pharmacies, medical practices and canton-authorised mail-order pharmacies.
Trust & reputation

ranQ Trust Score of Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung: 4.2 out of 5.0

Trust Score4.2/ 5.0

Very high

x

Data basis 96% · As of October 2026

Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung scores 57.0 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.39.824%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.73.510%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.88.08%
Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung scores 93.6 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.90.07%
Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung reaches a ranQ Trust Score of 4.2 out of 5.0 — rated «Very high». The rating draws, among other things, on 3.5 out of 5 stars from 17 customer reviews. The data basis is 96%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
3.5
of 5

Aggregated from 17 reviews across all connected sources

Sources
GGoogle3.517
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Knowledge

No knowledge articles yet

Once Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
The Circle 32/38
8058 Zürich
Opening hours
Mon
08:00 - 12:00, 13:00 - 17:00
Tue
08:00 - 12:00, 13:00 - 17:00
Wed
08:00 - 12:00, 13:00 - 17:00
Thu
08:00 - 12:00, 13:00 - 17:00
Fri
08:00 - 12:00, 13:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Foundation
UID
CHE-112.206.974
Founded
2005 · 21 years
Last commercial register change
July 3, 2026
Employees
51 to 100
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.97.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    VL
    Verein Lunge Zürich
    Zurich
    PP
    Paul Peter Alden Stiftung
    Zurich
    GS
    Gönnerstiftung See-Spital
    Horgen
    MG
    Modul2 GmbH
    Zurich
    AS
    ADRA Schweiz
    Zurich
    ST
    Stiftung Tox Info Suisse
    Zurich
    SL
    Stiftung LÄNDLI, Zweigniederlassung Ländli Züri
    Zurich
    SL
    Schweizerische Lungenstiftung
    Wald Zh